Induction of phenotype variance of naive T cell derived in vitro from mesenchymal stem cells
JIN Jian-gang;FENG Kai;SHI Bing-yi;CHEN Hu

..............page:1-4

The study of influence on cyclin and cyclin-dependent kinase inhibitor of Kasumi-1 cell treated with VPA
ZHAO Lei;ZHANG Zhi-hua;ZHU Cui-min;TIAN Wen-liang;HAO Chang-lai

..............page:5-8

zhi liao xing bai xi bao dan cai shu zhi liao gao bai xi bao man xing li xi bao bai xue bing de wei xun huan xue guan cha
li jun ; chai tie ; zuo jin long ; li jing

..............page:39-41

yi zuo rou bi xing wei zhu de lian he hua liao fang an zhi liao ji xing bai xue bing de liao xiao guan cha
ma jian ; wang zhi hong ; cao yong bin ; xu li zuo ; li xiao hong

..............page:41-42

xiao ji liang ia fang an zhi liao lao nian ren ji xing sui xi bai xue bing 20 li
jie jing rong ; zhang bin ; peng li ping

..............page:43-44

di 27 jie guo ji bing li xue shu hui yi guan yu lin ba liu de zui xin fen lei
wang jin fen

..............page:45-47

zuo yang rou ya zhong he s zary zong he zheng fen lei he fen qi de xiu ding fang an guo ji pi fu lin ba liu xue hui he ou zhou ai zheng yan jiu zhi liao te bie gong zuo zu de jian yi ( xu wan )
elise;olsen;eric;vonderheid;nicola;pimpinelli;rein;wiilemze;youn;kim;robert;knobler;herschel;zackheim;madeleine;duvic;teresa;estrach;stanford;lamberg;gary;wood;reinhard;dummer;annamari;ranki;gunter;burg;peter;heald;mark;pittelkow;maria-grazia;bemengo;wolfram;sterry;liliane;laroche;franz;trautinger;scan;whittaker; zhang pei hong ; chen hui shu

..............page:48-50,63

Research advances on cytogenetic and molecule mechanism of acute megakaryoblastic leukemia
WANG Ting;FU Rong

..............page:51-54

Current status of the application of PDT in the treatment of lymphomas
CHEN Wan-zi;HUANG Hui-fang;LIN Dong-hong

..............page:54-56

Expression and clinical significance of stromal cell-derived factor-1 and its receptor CXCR4 in leukemia
CHEN Chen;SHI Hao

..............page:57-59

Progression of proteasome inhibitor in the targeted therapy for hematological sistemetic malignant tumor
LI Ya-ni;MA Liang-ming

..............page:60-63

man xing li xi bao bai xue bing ji xing bian hun he xing bai xue bing yi li
zhang bin ; cai yan xia ; zuo chang qing ; zhang you cheng ; zhang su zhen ; fang sheng chun

..............page:44

yuan fa xing bang zuo lin ba liu yi li
meng xiu qin ; ai gong wen ; meng yue sheng

..............page:47

ji xing sui xi bai xue bing zi fa huan jie yi li
yin xiao hua ; yuan dong ; zhao zuo ; wu di ; yin de hou

..............page:64

Study on HLA alleles and haplotypes of 572 patients with acute lymphoblastic leukemia in southern Chinese Han
GAO Su-qing;CHENG Liang-hong;LU Liang;Zhuo Jia-cai;LI Ming;JING Shi-zheng;Zou Hong-yan;DENG Zhi-hui

..............page:9-11,14

Construction of human Par-4 eukaryotic expression vector and expression in K562 cells
QIN Jie;WANG Hong-wei;YANG Tao;ZHU Lei;ZHANG Li

..............page:12-14

The feature of TCR ζ chain gene expression in peripheral blood T cells from patients with multiple myeloma
CHEN Si;LI Yang-qiu;CHEN Shao-hua;YANG Li-jian

..............page:15-17

Clinical and pathological features of the sporadic Burkitt's lymphoma
HUANG Yuan-Jie;LIU Cui-ling;GONG Li-ping;HUANG Xin;DONG Ge-hong;SHI Yun-fei;ZHANG Dan-dan;ZHANG Jing;ZHOU Chun-ju;ZHANG Yong-hong;ZHANG Yan;GAO Zi-fen

..............page:18-20

The clinical and laboratorial characteristics of eleven nonsecretory myeloma
LIU Ai-jun;LI Li-hong

..............page:21-22

Expression level of VEGF in NHL and its clinical significance
YIN Song-mei;LI Yi-qing;XIE Shuang-fen;NIE Da-nian;MA Li-ping;WANG Xiu-ju;WU Yu-dan

..............page:23-25

A clinical analysis of myelodysplastic syndrome and aplastic anemia combined with autoimmune disease
XU Xiao-qian;WANG Jian-min;L Shu-qing;YANG Jian-min;CHEN Li;SONG Xian-min;ZHANG Wei-ping;HOU Jun

..............page:26-28

Survey on the intake of dietary nutrients for 132 aduit patients with acute and chronic leukemia
XU Zi-liang;WU Yun-tang;SUN Zhong;LI Rui;LI Hong-qiang;Qi Yu-mei;SONG Ji-chang;WANG Jian-xiang;HAN Ming-zhe;ZHANG Feng-kui;QIU Lu-gui;ZHU Xiao-fan;XIAO zhi-jian;YANG Ren-chi;ZHENG Yi-zhou;FENG Si-zhou;HAN Zhong-chao

..............page:39-31,34

DICE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin lymphoma
TAN Lin;ZENG Yun;XIE YU;YANG Jian

..............page:32-34

Aggressive natural killer-cell leukemia complicating multiple organ failure: one ease report and renew of literatures
ZHANG Yan-ming;SUN Yu-mei;LU Shu-huo;TANG Xiao-wen;ZHU Ming-qing

..............page:35-37

zi ti wai zhou xue zao xue yu xi bao yi zhi lian he mylotarg zhi liao ji xing sui xi bai xue bing yi li bing wen xian fu xi
hu yuan ; huang ren wei ; lin dong jun ; li xu dong ; he yi ; wang wen wen

..............page:38-39